Abstract:Purpose: This study aimed to evaluate antitumor activities and pharmacologic profiles of chimmitecan, a novel 9-small-alkyl-substituted lipophilic camptothecin, in comparison with irinotecan (CPT-11) and topotecan.Experimental Design: The in vitro cytotoxities of chimmitecan in human tumor cell lines and multidrug resistance (MDR) cells were evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide and sulforhodamin B assays. DNA relaxation, cleavage assays, and cellular band depletion assay were combined to delineate its effects on topoisomerase I. DNA damage, cell cycle arrest, and apoptosis were assessed using comet assay, flow cytometry, and DNA ladder analysis, respectively. The in vivo antitumor activities were measured in nude mice bearing human tumor xenografts.Results: Chimmitecan displayed more potent cytotoxicity than SN38 and topotecan. Neither a cross-resistance to chimmitecan in MDR cells nor an influence of human serum albumin in its cytotoxity was observed. Chimmitecan exhibited comparable effects on topoisomerase I compared with the reference drugs, including inhibiting topoisomerase I catalytic activity and trapping and stabilizing covalent topoisomerase I-DNA complexes. Furthermore, nanomolar levels of chimmitecan caused impressive DNA damage, G(2)-M phase arrest, and apoptosis in human leukemia HL60 cells. I.v. administration of chimmitecan inhibited the growth of HCT-116, MDA-MB-435, BEL-7402, and A549 human carcinoma xenografts in nude mice, with greater potency than CPT-11 against the latter two tumors models. Chimmitecan presented potent efficacy in A549 tumor model when given orally.Conclusions: Chimmitecan is a potent inhibitor of topoisomerase I and displays outstanding activity in vitro and in vivo. The substitution at the 9-position benefits chimmitecan a salient anti-MDR activity, stability in human serum albumin, improved solubility, and oral availability, which might favorably promise its therapeutic potential in clinical settings.

Research Progress of Status of 9-Nitrocamptothecin

A Phase I Pharmacokinetics Study of 9-Nitrocamptothecin in Patients with Advanced Solid Tumors.

Design, Synthesis, Mechanisms of Action, and Toxicity of Novel 20(S)-Sulfonylamidine Derivatives of Camptothecin As Potent Antitumor Agents

New polymorphs of 9-nitro-camptothecin prepared using a supercritical anti-solvent process

Identification and characterization of camptothecin tailoring enzymes in Nothapodytes tomentosa

Design and One-Pot Synthesis of New 7-Acyl Camptothecin Derivatives As Potent Cytotoxic Agents

Preparation of 9-Nitrocamptothecin Liposome and Its Pharmacokinetic after Pulmonary Delivery to Rats

Pharmacokinetics and Urinary Excretion of 9-Nitrocamptothecin Following Intravenous Administration of Lactone and Carboxylate Forms to Rats

Synthesis and biological assays of 9-(acylamino) homocamptothecins as DNA topoisomerase I inhibitors

Synthesis and Cytotoxic Activities of the Amino Acid-Conjugates of 10-Hydroxycamptothecin

Design, synthesis, and biological evaluation of novel 7-substituted 10,11-methylenedioxy-camptothecin derivatives against drug-resistant small-cell lung cancer in vitro and in vivo

Potent Antitumor Activity of 10-Methoxy-9-nitrocamptothecin.

Progress of Pharmaceutical Research on Hydroxycamptothecin

Synthesis and Antitumor Activities of Novel (20S)-O-selenoacetyl Camptothecin Derivatives.

Pharmacokinetics and Tissue Distribution in Tumor-bearing Mice After iv Administration of 9-Nitrocamptothecin with Different Lactone Ratios

Enhanced anti-tumor effect of 9-nitro-camptothecin complexed by hydroxypropyl-β-cyclodextrin and safety evaluation.

Synthesis and evaluation of 9-benzylideneamino derivatives of homocamptothecin as potent inhibitors of DNA topoisomerase I

Chimmitecan, A Novel 9-Substituted Camptothecin, With Improved Anticancer Pharmacologic Profiles In Vitro And In Vivo

F10, a new camptothecin derivative, was identified as a new orally–bioavailable, potent antitumor agent

Total Synthesis of 7-Ethyl-10-hydroxycamptothecin (SN38) and Its Application to the Development of C18-functionalized Camptothecin Derivatives.

Phytochemical analysis of Nothapodytes tomentosa and distribution and content of camptothecin and its analogues in four plants